Pavan Cheruvu
Algemeen Directeur bij Bitterroot Bio, Inc.
Actieve functies van Pavan Cheruvu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Bitterroot Bio, Inc.
 Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a company co-founded by Dr. Irv Weissman and Dr. Nick Leeper at Stanford University. The company is based in Palo Alto, CA. The company has closed a $145 million series A financing round co-led by Arch Venture Partners and Deerfield Management, with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others. Bitterroot Bio's research has uncovered the critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The company's lead candidate, BRB-002, targets the CD47/SIRP? pathway to address the underlying causes of atherosclerosis and vascular inflammation. The CEO of the company is Bruce Given. | Algemeen Directeur | - | - |
Loopbaan van Pavan Cheruvu
Eerdere bekende functies van Pavan Cheruvu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SIO GENE THERAPIES INC. | Directeur/Bestuurslid | 26-09-2018 | 31-01-2022 |
| Algemeen Directeur | 12-02-2018 | 31-01-2022 | |
| Hoofd Techniek/Wetenschap/O&O | - | 31-01-2022 | |
| President | - | 31-01-2022 | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Algemeen Directeur | 01-02-2018 | 01-12-2020 |
Opleiding van Pavan Cheruvu
| Duke University | Undergraduate Degree |
| University of Oxford | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a company co-founded by Dr. Irv Weissman and Dr. Nick Leeper at Stanford University. The company is based in Palo Alto, CA. The company has closed a $145 million series A financing round co-led by Arch Venture Partners and Deerfield Management, with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others. Bitterroot Bio's research has uncovered the critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The company's lead candidate, BRB-002, targets the CD47/SIRP? pathway to address the underlying causes of atherosclerosis and vascular inflammation. The CEO of the company is Bruce Given. | Commercial Services |
- Beurs
- Insiders
- Pavan Cheruvu
- Ervaring
